Home › Bayer sues Mylan over plans for generic cancer treatment drug
 

Keywords :   


Bayer sues Mylan over plans for generic cancer treatment drug

2015-02-09 20:10:04| Chemicals - Topix.net

Bayer Healthcare LLC is suing Mylan Inc. over the Southpointe drugmaker's application to make a generic version of cancer treatment Nexavar. Mylan confirmed the lawsuit in the U.S. District Court in Delaware by Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals Inc. and Onyx Pharmaceuticals over Mylan's abbreviated new drug application to the Food and Drug Administration for a 200 mg Sorafenib tablet.

Tags: plans treatment drug cancer

Category:Chemicals

Latest from this category

All news
23.11Weekly Recap: PPG, John Morikis, Sika Top This Weeks Stories
22.11Andrea Wagner Watts to Deliver Keynote Address at ACAs 2025 CoatingsTech Conference
22.11Hempels Infinity Silicone Hull Paint Recharger Launched for Yachts
22.11The Lehigh 56th Annual Short Course Website is Open
21.11allnex Announces Strategic Investment in East St. Louis Site
21.11Syensqo Expands Polymer Production Capacity
21.11¦nie¿ka Publishes Results for Three Quarters of 2024
21.11Sheboygan Paint Company Names New Customer Service Manager
Chemicals »
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11
24.11sobbat DB4R
24.11RC10
24.11 Knicks
24.11 W6S-JP001
24.11SALOMON XLT 150
More »